The Potential Effects of Cinnamon, Cumin, and Rosuvastatin on Lipid Profile among Iraqi Patients with Dyslipidemia
More details
Hide details
1
Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Iraq, Iraq
Submission date: 2025-02-16
Final revision date: 2025-08-04
Acceptance date: 2025-08-29
Publication date: 2025-12-11
Corresponding author
Qayssar Joudah Fadheel
Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Iraq, Iraq
Wiadomości Lekarskie 2025;(10):2008-2018
KEYWORDS
TOPICS
ABSTRACT
Aim:
Aims: to investigate effects of three spices on lipid profile and compare between them in patients with dyslipidaemia.
Material and methods:
Patients & Methods: This is randomized prospective clinical trials study; it is randomized prospective clinical trials study. Study includes patients that admitted to hospital and diagnosed with Dyslipidaemia and have high levels of lipid profile, while patients with normal level of lipid profile and patients who discharged from hospital without complete their tests are excluded. The sample includes 30 patients who admitted to hospital with dyslipidaemia disease.
Results:
Results: Highest readings are of Rosuvastatin that effected on Triglyceride with 53.1, Cholesterol with 75.4, High Density lipoprotein with 11.8 and Low Density lipoprotein with 65.5 were noticed, second highest readings are of Cumin that effected on Triglyceride with 31.6, Cholesterol with 47.5, High Density lipoprotein with 9.3 and the lowest reading is Low Density lipoprotein with 32 were noticed, lowest readings are of Cinnamon that effected on Triglyceride with 25.7, Cholesterol with 44.8, High Density lipoprotein with 8.4 and the second highest reading is Low Density lipoprotein with 43.9 were noticed on Dyslipidaemia patients living in Al-Najaf City.
Conclusions:
Conclusion: The study provides evidence that indicates the cumin, cinnamon both have antihyperlipidemic effect but less than Rosuvastatin in dyslipidaemia patients. It can be used as an adjuvant treatment with other drugs to decrease Triglyceride, cholesterol, Low Density Lipoprotein and increase High Density Lipoprotein levels.